Estimated Glomerular Filtration Rate Trajectories in HIV-Infected Subjects Treated With Different Ritonavir-Boosted Protease Inhibitors and Tenofovir Disoproxil Fumarate or Abacavir - Gianotti, Nicola; Galli, Laura; Poli, Andrea; Salpietro, Stefania; Nozza, Silvia; Carbone, Alessia; Merli, Marco; Ripa, Marco; Lazzarin, Adriano; Castagna, Antonella (Medicine (Baltimore), 2016)
Keywords: Adult; Anti-HIV Agents - administration & dosage; Anti-HIV Agents - adverse effects; Anti-HIV Agents - therapeutic use; CD4 Lymphocyte Count; Comorbidity; Dideoxynucleosides - therapeutic use; Drug Therapy, Combination; Emtricitabine - therapeutic use; Female; Glomerular Filtration Rate - drug effects; HIV Infections - drug therapy; HIV Protease Inhibitors - administration & dosage; HIV Protease Inhibitors - adverse effects; HIV Protease Inhibitors - therapeutic use; Humans; Lamivudine - therapeutic use; Lopinavir - therapeutic use; Male; Middle Aged; Observational Study; Retrospective Studies; Reverse Transcriptase Inhibitors - administration & dosage; Reverse Transcriptase Inhibitors - adverse effects; Reverse Transcriptase Inhibitors - therapeutic use; Ritonavir - therapeutic use; Tenofovir; Viral Load